Literature DB >> 1510459

Ticarcillin-clavulanic acid dosing ratio for treatment of experimental Staphylococcus aureus endocarditis.

J S Goodman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510459      PMCID: PMC191629          DOI: 10.1128/AAC.36.7.1585-a

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.

Authors:  E J Catherall; V Gillon; S Hurn; R Irwin; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Safety of ticarcillin disodium/potassium clavulanate.

Authors:  T C Tasker; A Cockburn; D Jackson; G Mellows; D White
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

3.  Pharmacology of ticarcillin combined with clavulanic acid in humans.

Authors:  B E Scully; N X Chin; H C Neu
Journal:  Am J Med       Date:  1985-11-29       Impact factor: 4.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.